BioCentury
ARTICLE | Clinical News

MG98: Phase II start

October 11, 2004 7:00 AM UTC

MYG began a 2-step Phase II trial of MG98 plus interferon alpha. The first step will evaluate the safety, pharmacokinetics and optimal dosing of the combination therapy in 30-50 chemotherapy-naive pat...